Biden nominates Arati Prabhakar as his top science adviser

Published 06/21/2022, 04:29 PM
Updated 06/21/2022, 04:31 PM
© Reuters. FILE PHOTO: Defense Advanced Research Projects Agency (DARPA) Director Arati Prabhakar takes part in an onstage interview at the Washington Ideas Forum in Washington, September 30, 2015. REUTERS/Jonathan Ernst

WASHINGTON (Reuters) - U.S. President Joe Biden on Tuesday nominated Arati Prabhakar as the new White House science adviser, who would be the first woman of color and first immigrant to hold such a role if confirmed by the Senate.

Prabhakar would head The Office of Science and Technology Policy at the White House. Her predecessor Eric Lander resigned from the post in February after violating the Biden administration's workplace policy.

© Reuters. FILE PHOTO: Defense Advanced Research Projects Agency (DARPA) Director Arati Prabhakar takes part in an onstage interview at the Washington Ideas Forum in Washington, September 30, 2015. REUTERS/Jonathan Ernst

Her portfolio will include issues ranging from climate change to the physical sciences. Prabhakar also will play an essential role in Cancer Moonshot 2.0 - an initiative personally important to Biden that aims to cut the cancer death rate in half over the next 25 years.

Prabhakar has previously led the Defense Advanced Research Projects Agency - a Pentagon entity that develops cutting-edge national security technologies - under former president Barack Obama, and the National Institute of Standards and Technology under former president Bill Clinton.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.